Genetic Analysis AS is a biotechnology company specializing in the development and commercialization of advanced diagnostic solutions based on gut microbiota analysis. Established to enhance the understanding of the human microbiome, the company focuses on providing actionable insights into gut health to both healthcare providers and patients. One of its core offerings is a patented test that analyzes gut bacteria profiles to aid in the diagnosis and management of gastrointestinal diseases, providing essential data for personalizing treatment strategies.

Operating at the intersection of biotechnology and healthcare, Genetic Analysis AS plays a significant role in the growing field of personalized medicine and gut health management. The company's technology helps in the identification and management of various conditions by utilizing a cutting-edge approach to microbial diagnostics. This enhances the ability of healthcare professionals to tailor treatments to the specific needs of patients based on their unique microbiota compositions. Genetic Analysis AS contributes to the broader healthcare industry by supporting improvements in diagnostic precision and patient care, helping to advance scientific research and clinical applications in microbiome science.